Unknown

Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants

SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth

Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection

Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma

Engaging Religious Leaders to Reduce Blood Pressures in Tanzanian Communities

Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania

Treatment Outcomes of Esophageal Cancer

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

SCAF-TB - Saving Children and Their Families From Tuberculosis: Implementation Research to Improve TB Preventive Treatment Initiation and Completion Rates Among Contact Persons in Tajikistan and Tanzania

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania

Acute Coronary Syndrome KCMC_1

Leveraging Community Health Workers and a Digital Health System to Improve the Timeliness of Child Well Visits

A Stigma Reduction Intervention at Time of Entry Into Antenatal Care to Improve PMTCT Services in Tanzania

Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)

Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis